Drug interactions in cardiovascular therapy.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001667:Binding, Competitive; D001682:Biological Availability; D001711:Biotransformation / Q000187:drug effects; D002301:Cardiac Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D011955:Receptors, Drug; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D011955:Receptors, Drug; D013566:Sympathomimetics